Therefore, we revealed that BBR can improve AS combined with NAFLD by regulating genes like MNDA, PIM2, DUSP6, CCL3, C5AR1, and FPR1, with the mechanism related to inflammation control. This evidence concerns the gene FPR1 and metabolic dysfunction-associated steatotic liver disease.